Overactive Bladder (OAB) Therapeutics Market Report

China Overactive Bladder (OAB) Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Aug 25, 2023
  • PAGES：193
  • REPORT CODE：GMM1755854
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Overactive Bladder (OAB) Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Astellas Pharma 

    • Pfizer 

    • Urovant Sciences

    • Teva Pharmaceutical Industries 

    • ONO Pharmaceutical 

    • Ferring 

    • Ion Channel Innovations 

    • Allergan 

    • Hisamitsu Pharmaceutical 

    • Kwang Dong Pharmaceutical 

    By Type:

    • Beta-3 Adrenoreceptor Agonists

    • Anticholinergic Agents

    By Application:

    • Other

    • Hosptial

    • Clinci

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Overactive Bladder (OAB) Therapeutics Market Overview 2018-2029

    • 1.1 China Overactive Bladder (OAB) Therapeutics Industry Development Overview

    • 1.2 China Overactive Bladder (OAB) Therapeutics Industry Development History

    • 1.3 China Overactive Bladder (OAB) Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Overactive Bladder (OAB) Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Overactive Bladder (OAB) Therapeutics Production Volume, Production Value and Growth Rate of Beta-3 Adrenoreceptor Agonists (2018-2029)

      • 1.4.2 China Overactive Bladder (OAB) Therapeutics Production Volume, Production Value and Growth Rate of Anticholinergic Agents (2018-2029)

    • 1.5 China Overactive Bladder (OAB) Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.2 China Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate of Hosptial (2018-2029)

      • 1.5.3 China Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate of Clinci (2018-2029)

    • 1.6 China Overactive Bladder (OAB) Therapeutics Market Analysis by Region

      • 1.6.1 North China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Overactive Bladder (OAB) Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Overactive Bladder (OAB) Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Overactive Bladder (OAB) Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Overactive Bladder (OAB) Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Overactive Bladder (OAB) Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Overactive Bladder (OAB) Therapeutics Industry Development

    Chapter 3 Overactive Bladder (OAB) TherapeuticsIndustry Chain Analysis

    • 3.1 Overactive Bladder (OAB) Therapeutics Industry Chain

    • 3.2 Overactive Bladder (OAB) Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Overactive Bladder (OAB) Therapeutics Market

    • 3.3 Overactive Bladder (OAB) Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Overactive Bladder (OAB) Therapeutics Market

    Chapter 4 China Overactive Bladder (OAB) Therapeutics Market, by Type

    • 4.1 China Overactive Bladder (OAB) Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Overactive Bladder (OAB) Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Overactive Bladder (OAB) Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Overactive Bladder (OAB) Therapeutics Production Volume and Growth Rate of Beta-3 Adrenoreceptor Agonists

      • 4.5.2 China Overactive Bladder (OAB) Therapeutics Production Volume and Growth Rate of Anticholinergic Agents

    Chapter 5 China Overactive Bladder (OAB) Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Overactive Bladder (OAB) Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate of Other

      • 5.5.2 China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate of Hosptial

      • 5.5.3 China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate of Clinci

    Chapter 6 China Overactive Bladder (OAB) Therapeutics Market, by Region

    • 6.1 China Overactive Bladder (OAB) Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Overactive Bladder (OAB) Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Overactive Bladder (OAB) Therapeutics Market Analysis

    • 7.1 North China Overactive Bladder (OAB) Therapeutics Market, by Type

    • 7.2 North China Overactive Bladder (OAB) Therapeutics Market, by Application

    Chapter 8 Central China Overactive Bladder (OAB) Therapeutics Market Analysis

    • 8.1 Central China Overactive Bladder (OAB) Therapeutics Market, by Type

    • 8.2 Central China Overactive Bladder (OAB) Therapeutics Market, by Application

    Chapter 9 South China Overactive Bladder (OAB) Therapeutics Market Analysis

    • 9.1 South China Overactive Bladder (OAB) Therapeutics Market, by Type

    • 9.2 South China Overactive Bladder (OAB) Therapeutics Market, by Application

    Chapter 10 East China Overactive Bladder (OAB) Therapeutics Market Analysis

    • 10.1 East China Overactive Bladder (OAB) Therapeutics Market, by Type

    • 10.2 East China Overactive Bladder (OAB) Therapeutics Market, by Application

    Chapter 11 Northeast China Overactive Bladder (OAB) Therapeutics Market Analysis

    • 11.1 Northeast China Overactive Bladder (OAB) Therapeutics Market, by Type

    • 11.2 Northeast China Overactive Bladder (OAB) Therapeutics Market, by Application

    Chapter 12 Southwest China Overactive Bladder (OAB) Therapeutics Market Analysis

    • 12.1 Southwest China Overactive Bladder (OAB) Therapeutics Market, by Type

    • 12.2 Southwest China Overactive Bladder (OAB) Therapeutics Market, by Application

    Chapter 13 Northwest China Overactive Bladder (OAB) Therapeutics Market Analysis

    • 13.1 Northwest China Overactive Bladder (OAB) Therapeutics Market, by Type

    • 13.2 Northwest China Overactive Bladder (OAB) Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Astellas Pharma 

        • 14.1.1 Astellas Pharma  Company Profile

        • 14.1.2 Astellas Pharma  Overactive Bladder (OAB) Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Pfizer 

        • 14.2.1 Pfizer  Company Profile

        • 14.2.2 Pfizer  Overactive Bladder (OAB) Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Urovant Sciences

        • 14.3.1 Urovant Sciences Company Profile

        • 14.3.2 Urovant Sciences Overactive Bladder (OAB) Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Teva Pharmaceutical Industries 

        • 14.4.1 Teva Pharmaceutical Industries  Company Profile

        • 14.4.2 Teva Pharmaceutical Industries  Overactive Bladder (OAB) Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 ONO Pharmaceutical 

        • 14.5.1 ONO Pharmaceutical  Company Profile

        • 14.5.2 ONO Pharmaceutical  Overactive Bladder (OAB) Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Ferring 

        • 14.6.1 Ferring  Company Profile

        • 14.6.2 Ferring  Overactive Bladder (OAB) Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Ion Channel Innovations 

        • 14.7.1 Ion Channel Innovations  Company Profile

        • 14.7.2 Ion Channel Innovations  Overactive Bladder (OAB) Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Allergan 

        • 14.8.1 Allergan  Company Profile

        • 14.8.2 Allergan  Overactive Bladder (OAB) Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Hisamitsu Pharmaceutical 

        • 14.9.1 Hisamitsu Pharmaceutical  Company Profile

        • 14.9.2 Hisamitsu Pharmaceutical  Overactive Bladder (OAB) Therapeutics Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Kwang Dong Pharmaceutical 

        • 14.10.1 Kwang Dong Pharmaceutical  Company Profile

        • 14.10.2 Kwang Dong Pharmaceutical  Overactive Bladder (OAB) Therapeutics Market Performance

        • 14.10.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Overactive Bladder (OAB) Therapeutics Industry Research Conclusions

    • 15.2 Overactive Bladder (OAB) Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Overactive Bladder (OAB) Therapeutics Industry Market Size (2018-2029)

    • Figure China Overactive Bladder (OAB) Therapeutics Production Volume, Production Value and Growth Rate of Beta-3 Adrenoreceptor Agonists (2018-2029)

    • Figure China Overactive Bladder (OAB) Therapeutics Production Volume, Production Value and Growth Rate of Anticholinergic Agents (2018-2029)

    • Figure China Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate of Hosptial (2018-2029)

    • Figure China Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate of Clinci (2018-2029)

    • Figure North China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Overactive Bladder (OAB) Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Overactive Bladder (OAB) Therapeutics Market Share by Type in 2018

    • Figure China Overactive Bladder (OAB) Therapeutics Market Share by Type in 2023

    • Figure China Overactive Bladder (OAB) Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Overactive Bladder (OAB) Therapeutics Production Volume and Growth Rate of Beta-3 Adrenoreceptor Agonists (2018-2023)

    • Figure China Overactive Bladder (OAB) Therapeutics Production Volume and Growth Rate of Anticholinergic Agents (2018-2023)

    • Figure China Overactive Bladder (OAB) Therapeutics Market Share by Application in 2018

    • Figure China Overactive Bladder (OAB) Therapeutics Market Share by Application in 2023

    • Figure China Overactive Bladder (OAB) Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate of Other (2018-2023)

    • Figure China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate of Hosptial (2018-2023)

    • Figure China Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate of Clinci (2018-2023)

    • Table China Overactive Bladder (OAB) Therapeutics Production Volume by Region (2018-2023)

    • Table China Overactive Bladder (OAB) Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Overactive Bladder (OAB) Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Overactive Bladder (OAB) Therapeutics Production Value by Region (2018-2023)

    • Table China Overactive Bladder (OAB) Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Overactive Bladder (OAB) Therapeutics Production Value Share by Region (2018-2023)

    • Table China Overactive Bladder (OAB) Therapeutics Sales Volume by Region (2018-2023)

    • Table China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Overactive Bladder (OAB) Therapeutics Sales Value by Region (2018-2023)

    • Table China Overactive Bladder (OAB) Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Overactive Bladder (OAB) Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Overactive Bladder (OAB) Therapeutics Production Volume by Type (2018-2023)

    • Table North China Overactive Bladder (OAB) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Overactive Bladder (OAB) Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Overactive Bladder (OAB) Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Overactive Bladder (OAB) Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Overactive Bladder (OAB) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Overactive Bladder (OAB) Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Overactive Bladder (OAB) Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Overactive Bladder (OAB) Therapeutics Production Volume by Type (2018-2023)

    • Table South China Overactive Bladder (OAB) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Overactive Bladder (OAB) Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Overactive Bladder (OAB) Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Overactive Bladder (OAB) Therapeutics Production Volume by Type (2018-2023)

    • Table East China Overactive Bladder (OAB) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Overactive Bladder (OAB) Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Overactive Bladder (OAB) Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Overactive Bladder (OAB) Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Overactive Bladder (OAB) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Overactive Bladder (OAB) Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Overactive Bladder (OAB) Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Overactive Bladder (OAB) Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Overactive Bladder (OAB) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Overactive Bladder (OAB) Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Overactive Bladder (OAB) Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Overactive Bladder (OAB) Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Overactive Bladder (OAB) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Overactive Bladder (OAB) Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Overactive Bladder (OAB) Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Overactive Bladder (OAB) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Astellas Pharma  Company Profile

    • Table Astellas Pharma  Overactive Bladder (OAB) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Pfizer  Company Profile

    • Table Pfizer  Overactive Bladder (OAB) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Urovant Sciences Company Profile

    • Table Urovant Sciences Overactive Bladder (OAB) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Industries  Company Profile

    • Table Teva Pharmaceutical Industries  Overactive Bladder (OAB) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table ONO Pharmaceutical  Company Profile

    • Table ONO Pharmaceutical  Overactive Bladder (OAB) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Ferring  Company Profile

    • Table Ferring  Overactive Bladder (OAB) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Ion Channel Innovations  Company Profile

    • Table Ion Channel Innovations  Overactive Bladder (OAB) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Allergan  Company Profile

    • Table Allergan  Overactive Bladder (OAB) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Hisamitsu Pharmaceutical  Company Profile

    • Table Hisamitsu Pharmaceutical  Overactive Bladder (OAB) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Kwang Dong Pharmaceutical  Company Profile

    • Table Kwang Dong Pharmaceutical  Overactive Bladder (OAB) Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US